Regenxbio Inc (RGNX)

Fixed asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	85,585	89,565	82,833	89,765	89,470	395,745	424,505	432,813	446,605	134,740	275,433	273,347	271,089	261,412	95,283	71,153	44,415	73,424	54,848	86,998
Property, plant and equipment	US$ in thousands	132,103	135,534	138,680	141,573	141,685	140,906	138,815	135,264	131,547	122,231	106,685	89,342	56,467	38,871	32,696	30,414	28,973	28,287	27,330	23,140
Fixed asset turnover		0.65	0.66	0.60	0.63	0.63	2.81	3.06	3.20	3.40	1.10	2.58	3.06	4.80	6.73	2.91	2.34	1.53	2.60	2.01	3.76

December 31, 2023 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $85,585K ÷ $132,103K
= 0.65

Regenxbio Inc's fixed asset turnover ratio has exhibited a declining trend over the past eight quarters. The ratio decreased steadily from 3.50 in Q1 2022 to 0.68 in Q4 2023. This indicates that the company's ability to generate revenue from its fixed assets has weakened significantly over this period. The sharp decline in fixed asset turnover from Q2 2022 to Q1 2023 may suggest inefficiencies in asset utilization or a decrease in sales relative to the value of fixed assets. Further analysis would be necessary to understand the specific factors contributing to this downward trend and to assess the company's overall operational efficiency and financial performance.